Primary Care in Rochester and Kasson > 자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

When you struggle to lose weight through diet and exercise alone, GLP-1 receptor agonists, medications like semaglutide (Wegovy) and tirzepatide (Zepbound), offer a powerful new tool. But before starting any treatment, it's important to weigh the benefits, drawbacks and alternatives to find what best fits your health goals and budget. Effective, clinically-proven weight loss: People typically lose 10% to 15% of their body weight over several months, with some tirzepatide trials showing up to 20% at the highest doses. Better blood sugar control and metabolic health as these drugs mimic a hormone that boosts insulin release, reduces glucagon and slows gastric emptying, resulting in improved HbA1c, lowering insulin resistance, blood pressure and cholesterol. Appetite regulation and satiety: By acting on brain and gut receptors, GLP-1 agonists curb cravings and help you eat smaller, more satisfying meals, supporting long-term habit change. By decreasing "food chatter," many people find that they can better sustain healthy habits when willpower starts to wane. High cost: Out-of-pocket expenses often run $800 to $1200 monthly, and weight-loss insurance coverage is inconsistent.

Various direct-to-consumer programs, such as those offered by the drug makers, can lower the cost to around $500 per month. Other online companies offer "compounded" versions of the medications, but this is not a recommended route to obtain weight-loss medications. Potential for lifelong use: Studies have shown that most people who start weight-loss medications regain their weight after stopping the drug. Weight regain can be prevented or slowed by adherence to a healthy diet and regular exercise, but this doesn't work for everyone. Short-term gastrointestinal side effects: Medication initiation and dose increases commonly trigger nausea and vomiting, diarrhea or constipation, bloating and stomach discomfort, fatigue, dizziness, headaches, and injection-site redness or itching. These symptoms often improve as the body adapts to the treatment. Long-term side effects: Emerging data and concerns include: Loss of muscle mass: Over 30% of weight loss on medications can be from muscle. This is not too different from what is observed with any weight-loss method, but scientists are concerned that muscle is not always regained when weight is regained after stopping treatment.

Reduced bone density: Sustained weight loss can accelerate bone mineral loss, raising fracture risk. Rare but serious risks: Pancreatitis, gallbladder disease, acute kidney injury and thyroid C-cell changes have been seen in animal studies. Uncharted decades-long effects: Potential neurocognitive, ocular (NAION optic neuropathy) or other organ-system impacts may only emerge with widespread, prolonged use. Bariatric surgery, including gastric bypass and sleeve gastrectomy, achieves weight loss by 20% to 30%. This often leads to diabetes remission and improves comorbidities. Despite the $18,000 to $23,000 procedure cost, surgery is usually more cost-effective in the long term than GLP1 use. Endoscopic intragastric balloons are less invasive and have lower upfront costs with a 10% to 15% weight loss. Still, the benefits are typically temporary and not as cost-effective as surgery or combined approaches. GLP-1 agonists are revolutionizing obesity care but are not a one-size-fits-all solution. Medication history and weight-related condition. Treatment goals (short-term versus long-term). Financial considerations and insurance coverage. Willingness to commit to lifestyle support (e.g., nutrition, exercise, behavior). Whether you are exploring medication, surgery or non-surgical devices, talk to your primary care clinician to find the path that's right for you. David Brennan, M.D., is a primary care physician in the Division of Community Internal Medicine, Geriatrics, and Palliative Care in Rochester, Minnesota. He focuses on prevention and treatment of a wide variety of common diseases.

Science continues to prove that the old adage "you are what you eat" is profoundly true. This is because you have trillions of microorganisms living in your gut, which are directly responsible for nearly every aspect of your health. These microbes make up what’s called your "gut microbiota." They are especially influential in determining your likelihood of gaining excessive weight, becoming obese, and developing obesity-related diseases like diabetes, heart disease, and premature death. The gut microbiome (the expressed genes of your gut microbiota) plays a major role in your metabolism through energy production, storage, and expenditure. So, it’s no surprise that science has found a strong connection between gut microbiome imbalance and MedicGLP Website metabolic syndrome. Yikes! If you have the wrong mix of microbes, Medic GLP it could be making it tough for you to get your health on track! Did you know: Scientists can actually look at your gut microbiome composition and tell with 90% accuracy if you are obese or lean. That’s pretty impressive, isn’t it?